SAB

Kenneth Pienta, M.D.

Kenneth Pienta is a highly-respected leader in the understanding of cancer metastases and the role of the tumor microenvironment in cancer development and immunosuppression. Dr. Pienta is the Donald S. Coffey Professor of Urology, as well as a Professor of Oncology, Pharmacology and Molecular Sciences, and Chemical and Biomolecular Engineering at Johns Hopkins University. Currently, he is the Director of Research at the Brady Urological Institute and also serves as the co-Director of the Johns Hopkins Individualized Health Initiative (Hopkins inHealth) to better define the practice of precision medicine. He has been the principal investigator on numerous local and national clinical trials and has a proven track record in developing multi-disciplinary translational research programs, diagnostics, and therapeutics. Dr. Pienta is the author of more than 550 peer-reviewed articles, and is a two-time American Cancer Society Clinical Research Professor Award recipient. Dr. Pienta received a B.A. in human biology from Johns Hopkins University and an M.D. from the Johns Hopkins University School of Medicine, and is board certified in oncology.